Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Mar;99(3):454–460. doi: 10.1111/j.1365-2249.1995.tb05572.x

Attenuation of immune complex nephritis in NZB/WF1 mice by a prostacyclin analogue.

Y Utsunomiya 1, M Ogura 1, T Kawamura 1, T Mitarai 1, N Maruyama 1, O Sakai 1
PMCID: PMC1534207  PMID: 7882569

Abstract

Although prostaglandins have been shown to inhibit the evolution of the nephritis in NZB/W mice, the mechanisms of this effect are unknown. To characterize such inhibition, we injected the prostacyclin (PGI2) analogue, beraprost, into NZB/W mice, using 0.5 mg, 1.0 mg or 5.0 mg beraprost/kg body weight of test animals three times in 1 week when the mice were 2 months old. Evaluation included measurement of urine albumin excretion, serological parameters and splenic T cell subset, as well as examination of renal histology by light and fluorescence microscopy. Mice given beraprost showed a marked decrease in urine albumin excretion and in glomerular hypercellularity compared with untreated controls. Maximal beneficial effects occurred when the dose was 5.0 mg/kg of beraprost. These effects correlated with a reduction of immune complex deposition in glomeruli. In addition, beraprost reduced serum levels of immunoglobulins and anti-double-stranded DNA antibodies, and decreased the number of helper (L3T4+) T cells in splenocytes. These results indicate that beraprost attenuates the nephritis of NZB/W mice, and that the source of this effect is the reduced production of autoantibodies and deposition of immune complexes in glomeruli.

Full text

PDF
454

Images in this article

456Fig. 2
on p.456
457Fig. 3
on p.457
458Fig. 4
on p.458

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boxer L. A., Allen J. M., Schmidt M., Yoder M., Baehner R. L. Inhibition of polymorphonuclear leukocyte adherence by prostacyclin. J Lab Clin Med. 1980 May;95(5):672–678. [PubMed] [Google Scholar]
  2. Burchiel S. W. PGI2 and PGD2 effects on cyclic AMP and human T-cell mitogenesis. Prostaglandins Med. 1979 Nov;3(5):315–320. doi: 10.1016/0161-4630(79)90073-9. [DOI] [PubMed] [Google Scholar]
  3. Clark W. F., Parbtani A., McDonald J. W., Taylor N., Reid B. D., Kreeft J. The effects of a thromboxane synthase inhibitor, a prostacyclin analog and PGE1 on the nephritis of the NZB/W F1 mouse. Clin Nephrol. 1987 Dec;28(6):288–294. [PubMed] [Google Scholar]
  4. Dubois E. L., Horowitz R. E., Demopoulos H. B., Teplitz R. NZB/NZW mice as a model of systemic lupus erythematosus. JAMA. 1966 Jan 24;195(4):285–289. [PubMed] [Google Scholar]
  5. Gerber J. G., Nies A. S. The hemodynamic effects of prostaglandins in the rat. Evidence for important species variation in renovascular responses. Circ Res. 1979 Mar;44(3):406–410. doi: 10.1161/01.res.44.3.406. [DOI] [PubMed] [Google Scholar]
  6. Gerber J. G., Payne N. A., Murphy R. C., Nies A. S. Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance. J Clin Invest. 1981 Mar;67(3):632–636. doi: 10.1172/JCI110077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Goodwin J. S., Messner R. P., Peake G. T. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation. J Clin Invest. 1978 Oct;62(4):753–760. doi: 10.1172/JCI109186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hara I., Izui S., Dixon F. J. Murine serum glycoprotein gp70 behaves as an acute phase reactant. J Exp Med. 1982 Feb 1;155(2):345–357. doi: 10.1084/jem.155.2.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Haurand M., Flohé L. Leukotriene formation by human polymorphonuclear leukocytes from endogenous arachidonate. Physiological triggers and modulation by prostanoids. Biochem Pharmacol. 1989 Jul 1;38(13):2129–2137. doi: 10.1016/0006-2952(89)90067-1. [DOI] [PubMed] [Google Scholar]
  10. Howie J. B., Helyer B. J. The immunology and pathology of NZB mice. Adv Immunol. 1968;9:215–266. doi: 10.1016/s0065-2776(08)60444-7. [DOI] [PubMed] [Google Scholar]
  11. Izui S., Kelley V. E., McConahey P. J., Dixon F. J. Selective suppression of retroviral gp70-anti-gp70 immune complex formation by prostaglandin E1 in murine systemic lupus erythematosus. J Exp Med. 1980 Dec 1;152(6):1645–1658. doi: 10.1084/jem.152.6.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kelley V. E., Winkelstein A., Izui S. Effect of prostaglandin E on immune complex nephritis in NZB/W mice. Lab Invest. 1979 Dec;41(6):531–537. [PubMed] [Google Scholar]
  13. Kunkel S. L., Chensue S. W. The role of arachidonic acid metabolites in mononuclear phagocytic cell interactions. Int J Dermatol. 1986 Mar;25(2):83–89. doi: 10.1111/j.1365-4362.1986.tb04543.x. [DOI] [PubMed] [Google Scholar]
  14. Lambert P. H., Dixon F. J. Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med. 1968 Mar 1;127(3):507–522. doi: 10.1084/jem.127.3.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lin C. Y. Improvement in steroid and immunosuppressive drug resistant lupus nephritis by intravenous prostaglandin E1 therapy. Nephron. 1990;55(3):258–264. doi: 10.1159/000185972. [DOI] [PubMed] [Google Scholar]
  16. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  17. Marcinkiewicz J., Chain B. M. Differential cytokine regulation by eicosanoids in T cells primed by contact sensitisation with TNP. Cell Immunol. 1993 Jul;149(2):303–314. doi: 10.1006/cimm.1993.1157. [DOI] [PubMed] [Google Scholar]
  18. McLeish K. R., Dyer R. D., Senitzer D. Suppression of murine T-cell mitogenesis by metabolic products of arachidonic acid. J Immunopharmacol. 1982;4(1-2):53–64. doi: 10.3109/08923978209031075. [DOI] [PubMed] [Google Scholar]
  19. McLeish K. R., Gohara A. F., Stelzer G. T., Wallace J. H. Treatment of murine immune complex glomerulonephritis with prostaglandin E2: dose--response of immune complex deposition, antibody synthesis, and glomerular damage. Clin Immunol Immunopathol. 1983 Jan;26(1):18–23. doi: 10.1016/0090-1229(83)90169-1. [DOI] [PubMed] [Google Scholar]
  20. Menè P., Abboud H. E., Dunn M. J. Regulation of human mesangial cell growth in culture by thromboxane A2 and prostacyclin. Kidney Int. 1990 Aug;38(2):232–239. doi: 10.1038/ki.1990.191. [DOI] [PubMed] [Google Scholar]
  21. Platt J. L., Michael A. F. Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine. J Histochem Cytochem. 1983 Jun;31(6):840–842. doi: 10.1177/31.6.6341464. [DOI] [PubMed] [Google Scholar]
  22. Poelstra K., Brouwer E., Baller J. F., Hardonk M. J., Bakker W. W. Attenuation of anti-Thy1 glomerulonephritis in the rat by anti-inflammatory platelet-inhibiting agents. Am J Pathol. 1993 Feb;142(2):441–450. [PMC free article] [PubMed] [Google Scholar]
  23. Radomski M. W., Palmer R. M., Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 1987 Nov;92(3):639–646. doi: 10.1111/j.1476-5381.1987.tb11367.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stahl R. A., Thaiss F., Haberstroh U., Kahf S., Shaw A., Schoeppe W. Cyclooxygenase inhibition enhances rat interleukin 1 beta-induced growth of rat mesangial cells in culture. Am J Physiol. 1990 Sep;259(3 Pt 2):F419–F424. doi: 10.1152/ajprenal.1990.259.3.F419. [DOI] [PubMed] [Google Scholar]
  25. Wofsy D., Seaman W. E. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med. 1985 Feb 1;161(2):378–391. doi: 10.1084/jem.161.2.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yoshiki T., Mellors R. C., Strand M., August J. T. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med. 1974 Oct 1;140(4):1011–1027. doi: 10.1084/jem.140.4.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yumura W., Sugino N., Nagasawa R., Kubo S., Hirokawa K., Maruyama N. Age-associated changes in renal glomeruli of mice. Exp Gerontol. 1989;24(3):237–249. doi: 10.1016/0531-5565(89)90015-6. [DOI] [PubMed] [Google Scholar]
  28. Zurier R. B., Sayadoff D. M., Torrey A. B., Rothfield N. F. Prostaglandin E treatment of NZB/NZW mice. Arthritis Rheum. 1977 Mar;20(2):723–728. doi: 10.1002/art.1780200213. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES